PATENT CLAIM ANALYSIS

Application Number: 16029299
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "093710"]

Abstract:
The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.

Claim (Index 2):
The method of  claim 1 , wherein modulation of expression and/or activity of the immune regulatory protein enhances cytotoxicity of the lymphocyte compared to a system in which the immune regulatory protein expression and/or activity is not modulated.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 95.0
- Lexical Diversity: 1.56667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15806756', '15403058', '15583658', '15096971', '15543220']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7597650784660668
- 35 USC 102 Novelty (BERT): 0.5762718125833729
- Combined Prediction Score: 0.7414157518777974
- Mean Citation Score: 400.062444
- Max Citation Score: 511.30402
- Similarity Product: 347.14069707225565

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test